Peri Cruiser CAR-T: An innovative platform to reduce on-target off-tumor toxicity of CAR-T therapy

被引:0
|
作者
Zhang, Shuangshuang [1 ]
Hao, Ruidong [1 ]
Wang, Hongye [1 ]
Yi, Qiao Yong [1 ]
Li Yantao [1 ]
Zhong, Yunpeng [1 ]
Sun, Minmin [1 ]
机构
[1] Suzhou Immunofoco Biotechnol Co Ltd, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2539
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A novel approach and model to limit cytokine release syndrome and off-tumor toxicity of synthetically enhanced CEA CAR-T cells
    Bartlett, Alexandra
    Eil, Robert M. D.
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [32] CAR-T Cell Therapy and Beyond
    Dotti, Gianpietro
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S4 - S4
  • [33] Building safety into CAR-T therapy
    Peters, Daniel T.
    Savoldo, Barbara
    Grover, Natalie S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [34] CAR-T Cell Therapy for Lymphoma
    Ramos, Carlos A.
    Heslop, Helen E.
    Brenner, Malcolm K.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 165 - 183
  • [35] Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities
    Vasic, Daniel
    Lee, Jong Bok
    Leung, Yuki
    Khatri, Ismat
    Na, Yoosu
    Abate-Daga, Daniel
    Zhang, Li
    SCIENCE IMMUNOLOGY, 2022, 7 (70)
  • [36] CAR-T Cell Therapy and the Neurointensivist
    Wijdicks, Eelco F. M.
    Rabinstein, Alejandro A.
    Lin, Yi
    NEUROCRITICAL CARE, 2024, : 691 - 694
  • [37] Allogene and Celularity move CAR-T therapy off the shelf
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2018, 36 (05) : 375 - 377
  • [38] Optimizing CAR-T Therapy for Glioblastoma
    Oliver Y. Tang
    Zev A. Binder
    Donald M. O’Rourke
    Stephen J. Bagley
    Molecular Diagnosis & Therapy, 2023, 27 : 643 - 660
  • [39] Optimizing CAR-T Therapy for Glioblastoma
    Tang, Oliver Y.
    Binder, Zev A.
    O'Rourke, Donald M.
    Bagley, Stephen J.
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (06) : 643 - 660
  • [40] Recent Advances in CAR-T Therapy
    Ali, Meher Binte
    CANCER CONTROL, 2024, 31